Compare · ACN vs AUGX
ACN vs AUGX
Side-by-side comparison of Accenture plc (ACN) and Augmedix Inc. (AUGX): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ACN and AUGX operate in Business Services (Consumer Discretionary), so they compete in similar markets.
- ACN carries a market cap of $174.50B.
- ACN has hit the wire 28 times in the past 4 weeks while AUGX has been quiet.
- ACN has more recent analyst coverage (25 ratings vs 10 for AUGX).
- Company
- Accenture plc
- Augmedix Inc.
- Price
- -
- -
- Market cap
- $174.50B
- -
- 1M return
- +30.51%
- -
- 1Y return
- +4.77%
- -
- Industry
- Business Services
- Business Services
- Exchange
- NYSE
- NASDAQ
- IPO
- 2001
- News (4w)
- 28
- 0
- Recent ratings
- 25
- 10
Accenture plc
Accenture plc, a professional services company, provides strategy and consulting, interactive, and technology and operations services worldwide. The company also provides outsourcing services. It serves communications, media, high tech, software, and platform companies; banking, capital market, and insurance industries; and consumer goods, retail, travel services, industrial, and life science industries, as well as clients in health, public service, chemicals and natural resources, energy, and utility sectors. Accenture plc has alliance relationships with Adobe, Alibaba, Amazon Web Services, Blue Yonder, Cisco, Dell, Google, HPE, IBM RedHat, Microsoft, Oracle, Pegasystems, Salesforce, SAP, ServiceNow, VMWare, Workday, Massachusetts Institute of Technology, Institut Polytechnique de Paris, CNH Industrial, and Reactive Technologies. It has an agreement with Duke Energy Corporation for the development of a technology platform designed to measure actual baseline methane emissions from natural gas distribution systems. The company was incorporated in 2009 and is based in Dublin, Ireland.
Augmedix Inc.
Augmedix, Inc. provides remote medical documentation solutions and live clinical support services in the United States. It offers software that is compatible with off-the-shelf, mobile client devices, which enables clinicians to communicate with remotely located documentation specialists (RDSs). The company's services include Augmedix Live, a real time service, in which RDSs provide medical documentation and live clinical support services; and Augmedix Notes, a non-real time product where RDSs offer medical documentation based upon recorded visits. Its clients include health systems and specialty groups. The company was founded in 2013 and is headquartered in San Francisco, California.
Latest ACN
- Chief Accounting Officer Burgum Melissa A covered exercise/tax liability with 59 units of Class A ordinary shares, decreasing direct ownership by 0.60% to 9,761 units (SEC Form 4)
- Director Price Paula A bought $199,848 worth of Class A ordinary shares (800 units at $249.81) (SEC Form 4)
- Chair and CEO Sweet Julie Spellman bought $3,001,041 worth of Class A ordinary shares (12,200 units at $245.99) (SEC Form 4)
- Chief Accounting Officer Burgum Melissa A sold $202,750 worth of Class A ordinary shares (811 units at $250.00) as part of a pre-agreed trading plan (SEC Form 4)
- SEC Form 144 filed by Accenture plc
- Co-CEO Asia Pacific Sekido Ryoji sold $1,430,826 worth of Class A ordinary shares (5,844 units at $244.84) (SEC Form 4)
- SEC Form 4 filed by Accenture plc
- SEC Form 4 filed by Accenture plc
- SEC Form 4 filed by Accenture plc
- SEC Form 4 filed by Accenture plc
Latest AUGX
- SEC Form 15-12G filed by Augmedix Inc.
- Director Redmile Group, Llc returned $75,402,504 worth of shares to the company (32,086,172 units at $2.35) (SEC Form 4)
- SEC Form 4 filed by Director Faulkner Robert C.
- Amendment: SEC Form SC 13D/A filed by Augmedix Inc.
- Director Febbo William J returned $382,070 worth of shares to the company (162,583 units at $2.35), closing all direct ownership in the company (SEC Form 4)
- SEC Form 4 filed by SVP, ENGINEERING Levy Tomer
- CHIEF TECHNOLOGY OFFICER Chatterjee Saurav returned $13,733 worth of shares to the company (5,844 units at $2.35), closing all direct ownership in the company (SEC Form 4)
- CHIEF OPERATING OFFICER Breber Sandra returned $47,693 worth of shares to the company (20,295 units at $2.35), closing all direct ownership in the company (SEC Form 4)
- Director O'Reilly Roderick H. returned $50,755 worth of shares to the company (21,598 units at $2.35), closing all direct ownership in the company (SEC Form 4)
- CHIEF FINANCIAL OFFICER Ginocchio Paul returned $319,118 worth of shares to the company (135,795 units at $2.35), closing all direct ownership in the company (SEC Form 4)